In Silico Evaluation of Chitosan's Antibacterial Potential Against Gram-Positive and Gram-Negative Bacteria

Authors

  • Selvira Maulidya Universitas Mataram
  • Susi Rahayu Univeristas Mataram
  • Lina Permatasari Universitas Mataram
  • Hudaynu Patya Putri Universitas Mataram
  • A'yuni Guban Juniarza Universitas Mataram

DOI:

https://doi.org/10.52434/jifb.v17i1.43047

Keywords:

antibiotic, biopolymer , molecular docking, molecular dynamics

Abstract

Chitosan, a natural biopolymer, has attracted attention for its potential antibacterial properties against a wide range of pathogens. The escalating crisis of antibiotic resistance necessitates the exploration of novel antibacterial agents effective against both Gram-positive and Gram-negative bacteria. This study aimed to predict the antibacterial potential of chitosan against Staphylococcus aureus (a Gram-positive bacterium) and Escherichia coli (a Gram-negative bacterium) using a comprehensive in silico approach. Short chitosan oligomers, specifically trimers, were used to ensure computational feasibility and reliable molecular docking, as full-length polymers are too large for standard docking algorithms. Molecular docking simulations were performed using AutoDock to investigate the interactions between 13 chitosan compounds and the essential bacterial protein DNA gyrase, a key enzyme involved in DNA replication and repair. Binding affinities, interaction patterns (such as hydrogen bonding and hydrophobic contacts), and conformational changes were analyzed. The ligand showing the most favorable docking profile was further evaluated via molecular dynamics simulations using OpenMMDL to assess the stability of the complex over time. The results indicated that the chitosan derivatives, namely aminoethyl chitosan and dimethylaminoethyl chitosan, interact favorably with DNA gyrase in S. aureus and E. coli, respectively, with differential binding energies and interaction modes suggesting potential variations in inhibitory mechanisms between Gram-positive and Gram-negative bacteria. These computational findings support the potential of chitosan as a broad-spectrum antibacterial agent and provide a theoretical framework to guide further in vitro and in vivo validation of chitosan as a novel antibacterial compound.

References

1. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.

2. Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010;2(5):1–17.

3. Edo GI, Yousif E, Al-Mashhadani MH. Chitosan: An overview of biological activities, derivatives, properties, and current advancements in biomedical applications. Carbohydr Res. 2024;542.

4. El-Araby A, Janati W, Ullah R, Ercisli S, Errachidi F. Chitosan, chitosan derivatives, and chitosan-based nanocomposites: eco-friendly materials for advanced applications (a review). Front Chem. 2023;11:01–21.

5. Husni P, Junaedi J, Gozali D. Penentuan aktivitas antibakteri kitosan Cilamaya terhadap Staphylococcuss aureus. Farmasains J Ilm Ilmu Kefarmasian. 2024;11(1):36–47.

6. Li J, Zhuang S. Antibacterial activity of chitosan and its derivatives and their interaction mechanism with bacteria: current state and perspectives. Eur Polym J. 2020;138:1–12.

7. Ardean C, Davidescu CM, Nemeş NS, Negrea A, Ciopec M, Duteanu N, et al. Factors influencing the antibacterial activity of chitosan and chitosan modified by functionalization. Int J Mol Sci. 2021;22(14):1–28.

8. Verlee A, Mincke S, Stevens C V. Recent developments in antibacterial and antifungal chitosan and its derivatives. Carbohydr Polym. 2017;164:268–83.

9. Kairys V, Baranauskiene L, Kazlauskiene M, Matulis D, Kazlauskas E. Binding affinity in drug design: experimental and computational techniques. Expert Opin Drug Discov. 2019;14(8):755–68.

10.Morris GM, Huey R, Olson AJ. Using autodock for ligand-receptor docking. Vol. 24, Current Protocols in Bioinformatics. 2008. p. 1–40.

11.Zheng J, Frisch MJ. Efficient geometry minimization and transition structure optimization using interpolated potential energy surfaces and iteratively updated hessians. J Chem Theory Comput. 2017;13(12):6424–32.

12.Yang Y, Gupta VK, Amiri H, Pan J, Aghbashlo M, Tabatabaei M, et al. Recent developments in improving the emulsifying properties of chitosan. Int J Biol Macromol. 2023;239.

13.Yilmaz Atay H. Antibacterial activity of chitosan-based systems. In: Functional Chitosan: Drug Delivery and Biomedical Applications. Springer; 2019. p. 457–89.

14.Shankar S, Rhim JW. Preparation of sulfur nanoparticle-incorporated antimicrobial chitosan films. Food Hydrocoll. 2018;82:116–23.

15.Helander IM, Nurmiaho-Lassila EL, Ahvenainen R, Rhoades J, Roller S. Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. Int J Food Microbiol. 2001;71(2–3):235–44.

16.Duan C, Meng X, Meng J, Khan MIH, Dai L, Khan A, et al. Chitosan as a preservative for fruits and vegetables: a review on chemistry and antimicrobial properties. J Bioresour Bioprod. 2019;4(1):11–21.

17.Hollingsworth SA, Dror RO. Molecular dynamics simulation for all. Neuron. 2018;99(6):1129–43.

18.Haq FU, Abro A, Raza S, Liedl KR, Azam SS. Molecular dynamics simulation studies of novel β-lactamase inhibitor. J Mol Graph Model. 2017;74:143–52.

19.De Vivo M, Masetti M, Bottegoni G, Cavalli A. Role of molecular dynamics and related methods in drug discovery. J Med Chem. 2016;59(9):4035–61.

20.Azzam KM Al. SwissADME and pkCSM webservers predictors: an integrated online platform for accurate and comprehensive predictions for in silico ADME/T properties of artemisinin and its derivatives. Kompleks Ispolz Miner Syra. 2023;325(2):14–21.

21.Ferreira LLG, Andricopulo AD. ADMET modeling approaches in drug discovery. Vol. 24, Drug Discovery Today. 2019. p. 1157–65.

Downloads

Published

2026-01-30

Issue

Vol. 17 No. 1 (2026): Jurnal Ilmiah Farmako Bahari

Section

Research Article

License

Copyright (c) 2026 Jurnal Ilmiah Farmako Bahari

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

or all articles published in Jurnal Ilmiah Farmako Bahari, the copyright is retained by the journal. Articles are published under the terms of Creative Commons Attribution-ShareAlike 4.0 International License (CC-BY-SA 4.0) .

For Authors:

  • Any article on the copyright is retained by the author(s).
  • The author grants the journal, right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles of work (eg, post-institutional repository) or publish it in a book, with acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process, as can lead to productive exchanges, as well as earlier and greater citation of published work.
  • The article and any associated published material is distributed under the Creative Commons Attribution-ShareAlike 4.0 International License

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)